HOLX News and Press, Hologic Inc. From 06/25/24

2024-06-25 10:29:34 ET More on S&P 500 Index: Odds For A Soft Landing Improve S&P 6300? Is That Outside The Realm Of Possibility? Nervous Calm Hangs Over The Markets Nasdaq, S&P, Dow are mixed after selloff in tech stocks Is the Nvidia-led...

2024-05-26 09:55:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

2024-05-22 14:42:59 ET More on Hologic Hologic: Women's Health Play Looks Healthier Itself Hologic, Inc. (HOLX) Q2 2024 Earnings Call Transcript Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M Hologic Q2 2024 Earnings Preview ...

2024-05-13 03:56:51 ET Summary Hologic's women's health business benefited from the pandemic but is now facing headwinds that will end in 2024. The company has a strong balance sheet, solid track record, and reasonable valuation, making it an attractive investment. Hologic rec...

2024-05-02 23:24:08 ET Call Start: 16:30 Call End: 17:24 Hologic, Inc. (HOLX) Q2 2024 Earnings Conference Call May 2, 2024 16:30 ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President & Chief Executiv...

2024-05-02 16:05:05 ET Read the full article on Seeking Alpha For further details see: Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M

– Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comp...

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

2024-05-01 17:20:29 ET More on Hologic Hologic: Prospects For Growth As Headwinds Disappear Hologic, Inc. (HOLX) Q1 2024 Results - Earnings Call Transcript Hologic digital cytology system wins FDA approval Hologic Non-GAAP EPS of $0.98 beats by $0.03, revenue...

2024-04-29 16:17:17 ET More on Hologic Hologic: Prospects For Growth As Headwinds Disappear Hologic digital cytology system wins FDA approval Hologic Non-GAAP EPS of $0.98 beats by $0.03, revenue of $1.01B beats by $26.42M Seeking Alpha’s Quant Rating ...